14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of BIIB
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Stronger technical forecast for Biogen Inc. stock price after Monday trading.
(Updated on Apr 15, 2024)

Sell candidate since Apr 02, 2024 Loss -5.22% PDF

The Biogen Inc. stock price fell by -0.696% on the last day (Monday, 15th Apr 2024) from $198.18 to $196.80. During the last trading day the stock fluctuated 1.57% from a day low at $196.45 to a day high of $199.53. The price has fallen in 7 of the last 10 days and is down by -8.39% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -70 thousand shares and in total, 1 million shares were bought and sold for approximately $227.04 million.

The stock lies in the middle of a falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -18.60% during the next 3 months and, with a 90% probability hold a price between $156.96 and $172.05 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Check out how to make money doing surveys! Ad

BIIB Signals & Forecast

There are few to no technical positive signals at the moment. The Biogen Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $202.22 and $215.26. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, March 11, 2024, and so far it has fallen -14.46%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Biogen Inc. stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $3.08 between high and low, or 1.57%. For the last week, the stock has had daily average volatility of 2.17%.

Biogen Inc. is oversold on RSI14 (24). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (BIIB) For The Upcoming Trading Day Of Tuesday 16th

For the upcoming trading day on Tuesday, 16th we expect Biogen Inc. to open at $197.59, and during the day (based on 14 day Average True Range), to move between $192.21 and $201.39, which gives a possible trading interval of +/-$4.59 (+/-2.33%) up or down from last closing price. If Biogen Inc. takes out the full calculated possible swing range there will be an estimated 4.66% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $219.31, some $22.51 (11.44%) from the current price of $196.80, our system finds the risk reward not very attractive.

Is Biogen Inc. stock A Buy?

Biogen Inc. holds several negative signals and is within a falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

Current score: -4.616 Sell Candidate Upgraded

Predicted Opening Price for Biogen Inc. of Tuesday, April 16, 2024

Fair opening price April 16, 2024 Current price
$197.59 ( 0.403%) $196.80

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for BIIB

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 200.67 1.97 %
R2 199.50 1.37 %
R1 198.77 1.00 %
Current price: 196.80
Support S1 196.42 -0.195 %
S2 195.69 -0.564 %
S3 194.51 -1.16 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 226.65 15.17 %
R2 220.74 12.16 %
R1 219.31 11.44 %
Current price 196.80
Support S1 0 .
S2 0 .
S3 0 .

FAQ

What is the symbol for Biogen Inc. Stock and on which exchange is it traded?
The symbol for Biogen Inc. is BIIB and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Biogen Inc. Stock?
Biogen Inc. holds several negative signals and is within a falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

How to buy Biogen Inc. Stock?
Biogen Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Biogen Inc. Stock.

What's the current price of Biogen Inc. Stock?
As of the end of day on the 2024-04-15, the price of an Biogen Inc. (BIIB) share was $196.80.

What is the 52-week high and low for Biogen Inc. Stock?
The 52-week high for Biogen Inc. Stock is $319.76 and the 52-week low is $196.45.

What is the market capitalization of Biogen Inc. Stock?
As of the 2024-04-15, the market capitalization of Biogen Inc. is 28.607B.

When is the next earnings date for Biogen Inc.?
The upcoming earnings date for Biogen Inc. is Apr 24, 2024.
Click to get the best stock tips daily for free!

About Biogen Inc.

Biogen. Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an etanercept biosimilar referencing ENBREL; ADUHELM for the treatment of Alzheimer's disease; IMRALDI, an ad... BIIB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT